Navigation Links
EMBO welcomes 55 leading life scientists as members
Date:5/9/2012

Heidelberg, Germany, 9 May 2012 Fifty-five life scientists from Europe and around the world were today recognised by EMBO for their excellence in research. Forty-eight of the researchers are from Europe and neighbouring countries while seven scientists from Argentina, Australia, South Korea and the United States join as Associate Members. In total, EMBO membership now comprises almost 1,550 life scientists in the international scientific community.

EMBO elects new members annually on the basis of scientific excellence. The new members represent a broad cross-section of the life sciences. The latest scientists to join the group come from 17 different countries and include 13 female scientists recognized for their contributions to life science research.

The new nominees include the first ever Associate Members in South Korea and Argentina. "Our members are the basis for the excellent international reputation of EMBO and its increasingly global orientation. We welcome this group of exceptional scientists and look forward to their fresh input and ideas," said EMBO Director Maria Leptin.

The selected researchers will help shape the direction of the life sciences in Europe and beyond by their involvement with the activities of the organization. EMBO Members provide scientific input such as acting on advisory editorial boards of the four scientific journals of the organization, serving on selection committees for EMBO Programmes and giving general advice to the scientific community.

A list of all new EMBO Members and Associate Members accompanies this announcement.


'/>"/>
Contact: barry.whyte@embo.org
communications@embo.org
0049-622-188-91108
European Molecular Biology Organization
Source:Eurekalert

Page: 1

Related biology news :

1. bioMETRX, Inc. Welcomes Residential and Commercial Security Expert to Board of Directors
2. Chinas new Climate Center welcomes citizen scientists
3. Agronomy Society welcomes USDA Mississippi River Basin Initiative
4. Chip Supply Welcomes Lupton Associates to Sales Team
5. March of Dimes welcomes FDA approval of progesterone injections
6. National Zoo Welcomes Whooping Crane
7. Society of Interventional Radiology Foundation welcomes corporate gift from Sirtex Medical
8. EMBO honors 59 leading life scientists
9. UCSF Fresno leading-edge study lends hope to emphysema patients
10. Scientists identify cell changes leading to impaired artificial kidney function
11. InvoTech Selects M2SYS Technology for Leading-Edge Fingerprint Software Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... 7, 2017 Report Highlights The ... from $8.3 billion in 2016 at a compound annual ... Report Includes - An overview of the global ... with data from 2015 and 2016, and projections of ... of the market on the basis of product type, ...
(Date:2/3/2017)... 3, 2017  Texas Biomedical Research Institute announced that its ... Schlesinger as the Institute,s new President and CEO. Dr. ... 31, 2017. He is currently the Chair of the Department ... for Microbial Interface Biology at Ohio State University. ... President and CEO of Texas Biomed," said Dr. James ...
(Date:2/1/2017)... 2017 IDTechEx Research, a leading provider of ... the availability of a new report, Sensors for Robotics: Technologies, ... Reading ... ... Source: IDTechEx Report "Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027: ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... BEIJING, Feb. 23, 2017 China Biologic Products, Inc. ... integrated plasma-based biopharmaceutical company in China, today announced its financial ... Fourth Quarter 2016 Financial Highlights ... increased by 21.7% in RMB terms, or increased by 13.6% ... the same quarter of 2015. Gross profit ...
(Date:2/24/2017)... -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing ... Leader event to highlight new clinical data that will ... the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and the Company,s ... in-person and via live webcast on Tuesday, February 28 ... the Lotte New York Palace Hotel in ...
(Date:2/23/2017)... Calif., Feb. 23, 2017 ... dollars, except per share data, unaudited)Three Months Ended December ... BioMarin Revenue $     ... 22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... /PRNewswire/ - The Fight Against Cancer Innovation Trust (FACIT) ... pleased to report that Fusion Pharmaceuticals Inc. (Fusion) has ... Johnson Innovation – JJDC, Inc. (JJDC) as the lead ... Biotechnology Partners, and Genesys Capital, as well as founding ... ...
Breaking Biology Technology: